Cryoport's mve biological solutions expands high-efficiency cryogenic freezer series with answer to evolving needs of fertility clinics, biorepositories and clinical laboratories

Nashville, tenn. , march 12, 2025 /prnewswire/ -- cryoport, inc. (nasdaq: cyrx) ("cryoport" or "the company"), a global leader in supply chain solutions for the life sciences, today announced the launch of mve biological solutions' ("mve") high-efficiency 800 c, the latest addition to its next-generation high-efficiency ("he") series of cryogenic freezers.
CYRX Ratings Summary
CYRX Quant Ranking